Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Current pharmacogenomics and personalized medicine - 11(2013), 1 vom: 24. März, Seite 1-4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ozdemir, Vural [VerfasserIn] |
|---|
| Anmerkungen: |
Date Revised 21.10.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM226158071 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM226158071 | ||
| 003 | DE-627 | ||
| 005 | 20231224070816.0 | ||
| 007 | tu | ||
| 008 | 231224s2013 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0754.xml |
| 035 | |a (DE-627)NLM226158071 | ||
| 035 | |a (NLM)23531886 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ozdemir, Vural |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Revised 21.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Genomics and development | |
| 650 | 4 | |a P5 medicine | |
| 650 | 4 | |a STS and organizations | |
| 650 | 4 | |a genomics without borders | |
| 650 | 4 | |a global governance of biotechnology innovation and uncertainty | |
| 650 | 4 | |a public health pharmacogenomics | |
| 650 | 4 | |a responsible innovation | |
| 650 | 4 | |a theranostic medicine | |
| 700 | 1 | |a Borda-Rodriguez, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Dove, Edward S |e verfasserin |4 aut | |
| 700 | 1 | |a Ferguson, Lynnette R |e verfasserin |4 aut | |
| 700 | 1 | |a Huzair, Farah |e verfasserin |4 aut | |
| 700 | 1 | |a Manolopoulos, Vangelis G |e verfasserin |4 aut | |
| 700 | 1 | |a Masellis, Mario |e verfasserin |4 aut | |
| 700 | 1 | |a Milius, Djims |e verfasserin |4 aut | |
| 700 | 1 | |a Warnich, Louise |e verfasserin |4 aut | |
| 700 | 1 | |a Srivastava, Sanjeeva |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current pharmacogenomics and personalized medicine |d 2008 |g 11(2013), 1 vom: 24. März, Seite 1-4 |w (DE-627)NLM187562679 |x 1875-6921 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2013 |g number:1 |g day:24 |g month:03 |g pages:1-4 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2013 |e 1 |b 24 |c 03 |h 1-4 | ||